Krognes Steve E.
Related Filers (4)
- Denali Therapeutics Inc. (34)
- Guardant Health, Inc. (11)
- Corvus Pharmaceuticals, Inc. (7)
- Gritstone bio, Inc. (6)
- Show More ...
Other (3)
144
Tuesday, 2/13/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 1/5/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 8/21/2023
Filing for proposed sale of securities under Rule 144
Ownership (55)
4
Thursday, 2/15/2024
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/1/2024
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/9/2024
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/2/2024
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/4/2023
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/1/2023
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/2/2023
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/5/2023
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/23/2023
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/1/2023
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/21/2023
Gritstone bio, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/15/2023
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/10/2023
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/9/2023
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/23/2022
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/11/2022
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/21/2022
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 7/11/2022
Guardant Health, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/22/2022
Gritstone bio, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/15/2022
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/11/2022
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/7/2022
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/19/2021
Gritstone bio, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/23/2021
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/16/2021
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/16/2021
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/11/2021
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/20/2021
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/6/2021
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/24/2020
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/20/2020
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/22/2020
Gritstone Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/12/2020
Corvus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 4/1/2020
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/1/2020
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/23/2020
Corvus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/12/2020
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/22/2019
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/24/2019
Corvus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/20/2019
Gritstone Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/11/2019
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/27/2018
Gritstone Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/22/2018
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/25/2018
Corvus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/28/2018
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2017
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/7/2017
Denali Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/9/2017
Corvus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/24/2016
Corvus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/22/2016
Corvus Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities